» Articles » PMID: 9658378

Propofol Concentrations in Whole Blood: Influence of Anticoagulants and Storage Time

Overview
Publisher Thomson Reuters
Specialty Pharmacology
Date 1998 Jul 11
PMID 9658378
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Blood samples for propofol determination are collected with oxalate, heparin and EDTA, but we have not found any study comparing the influence of those anticoagulants on propofol concentrations. This study was carried out on 50 samples from patients taking propofol for anesthesia or cerebral protection. First, 26 samples were simultaneously collected into tubes containing lithium heparin or sodium fluoride potassium oxalate as anticoagulant. In a second investigation, 24 samples were simultaneously collected into tubes containing heparin or EDTA. Propofol was assayed by HPLC 2 days after sampling and 2 weeks later. In the first assay, propofol concentration in samples collected with heparin were similar to those collected with oxalate (3.65 +/- 3.50 vs. 3.62 +/- 3.49 mg/l, ns) or EDTA (3.89 +/- 2.58 vs. 3.84 +/- 2.67 mg/L, ns). After storing for 2 weeks at 4 degrees C, propofol concentrations were slightly but insignificantly higher than in the first assay in samples collected with heparin (3.58 +/- 3.24 vs. 3.40 +/- 2.92 mg/l, ns), slightly higher in samples with oxalate (3.86 +/- 3.49 vs. 3.62 +/- 3.49 mg/l, p = 0.06), and slightly but significantly lower in samples with EDTA (3.63 +/- 2.67 vs. 3.84 +/- 2.67 mg/l, p < 0.05). It is concluded that the three anticoagulants used in this study seem to be suitable for determination of propofol concentration in whole blood, and that the stability of propofol concentration when samples are stored at 4 degrees C for up 2 weeks is acceptable.

Citing Articles

The influence of storage time and temperature on propofol concentrations in canine blood and plasma.

Cox S, Bailey J, Okafor C, Seddighi R, Doherty T PeerJ. 2017; 5:e3476.

PMID: 28674652 PMC: 5494168. DOI: 10.7717/peerj.3476.


Direct assessment of the antioxidant properties of midazolam by electron spin resonance spectroscopy.

Hata M, Kobayashi K, Yoshino F, Yoshida A, Sugiyama S, Miyamoto C J Anesth. 2011; 25(5):765-9.

PMID: 21688076 DOI: 10.1007/s00540-011-1184-6.